Mark E. Schurdak
Impact in
- Cancer Research top 5%
- Carcinogens and Genotoxicity Assessment
- Cancer, Lipids, and Metabolism
- Hepatology top 10%
- Hepatitis C virus research
Papers in
-
- Carcinogens and Genotoxicity Assessment 10
-
- Computational Drug Discovery Methods 8
- Co-authors
- Kurt Randerath (9 shared papers)D. Lansing Taylor (17 shared papers)Lawrence A. Vernetti (11 shared papers)Erika Randerath (2 shared papers)Andrew M. Stern (13 shared papers)Stephen W. Fesik (4 shared papers)Susan E. Morgan-Lappe (4 shared papers)Albert Gough (10 shared papers)
- Journals
- SLAS DISCOVERY (6 papers)Carcinogenesis (5 papers)Scientific Reports (2 papers)Oncogene (2 papers)Antiviral Research (1 paper)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Mark E. Schurdak
49 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 103
- Cancer Research 455
- Hepatology 77
- Molecular Biology 547
- Computational Theory and Mathematics 124
- Biophysics 47
Countries citing papers authored by Mark E. Schurdak
This map shows the geographic impact of Mark E. Schurdak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Schurdak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Schurdak more than expected).
Fields of papers citing papers by Mark E. Schurdak
This network shows the impact of papers produced by Mark E. Schurdak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Schurdak. The network helps show where Mark E. Schurdak may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Schurdak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1985 | 130 | |
| 2 | 2014 | 128 | |
| 3 | 2007 | 117 | |
| 4 | 2007 | 114 | |
| 5 | 2014 | 99 | |
| 6 | 2019 | 89 | |
| 7 | 1991 | 85 | |
| 8 | 2007 | 67 | |
| 9 | 2017 | 64 | |
| 10 | 2006 | 58 | |
| 11 | 2011 | 57 | |
| 12 | 2007 | 52 | |
| 13 | 2008 | 51 | |
| 14 | 2005 | 46 | |
| 15 | 2014 | 46 | |
| 16 | 2016 | 41 | |
| 17 | 1988 | 38 | |
| 18 | 2020 | 36 | |
| 19 | 2020 | 33 | |
| 20 | Effects of route of administration on tissue distribution of DNA adducts in mice: comparison of 7H-dibenzo(c,g)carbazole, benzo(a)pyrene, and 2-acetylaminofluorene. | 1989 | 32 |
About Mark E. Schurdak
Mark E. Schurdak is a scholar working on Cancer Research, Computational Theory and Mathematics, Biophysics, Molecular Biology and Pharmacology, having authored 50 papers that have together received 1.9k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (10 papers), Computational Drug Discovery Methods (8 papers), 3D Printing in Biomedical Research (5 papers), Cell Image Analysis Techniques (4 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Chemical Synthesis and Analysis (3 papers) and Genetic Neurodegenerative Diseases (2 papers). The work is most often cited by research in Cancer Research (455 citations), Hepatology (77 citations), Molecular Biology (547 citations), Computational Theory and Mathematics (124 citations) and Biophysics (47 citations). Mark E. Schurdak has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Kurt Randerath, D. Lansing Taylor, Lawrence A. Vernetti, Erika Randerath, Andrew M. Stern, Stephen W. Fesik, Susan E. Morgan-Lappe, Albert Gough, Kenneth M. Comess and Ramesh Chand Gupta. Their work appears in journals such as SLAS DISCOVERY, Carcinogenesis, Scientific Reports, Oncogene and Antiviral Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.